E-LIB Suche - Ergebnisse für: Sargiannidou, I

1

Efficacy of AAV serotypes to target Schwann cells after int..:

Kagiava, A. ; Richter, J. ; Tryfonos, C....
Scientific Reports. 11 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

2

Gene replacement therapy after neuropathy onset provides th..:

Kagiava, A ; Richter, J ; Tryfonos, C...
Human Molecular Genetics. 28 (2019) 21 - p. 3528-3542 , 2019

Link: https://doi.org/10.1093/..

3

Intrathecal gene therapy in mouse models expressing CMT1X m..:

Kagiava, A ; Karaiskos, C ; Richter, J...
Human Molecular Genetics. 27 (2018) 8 - p. 1460-1473 , 2018

Link: https://doi.org/10.1093/..

4

Gene replacement therapy in two Golgi-retained CMT1X mutant..:

Kagiava, A ; Karaiskos, C ; Lapathitis, G...
https://discovery.ucl.ac.uk/id/eprint/10175938/1/1-s2.0-S2329050123001134-main.pdf. , 2023

Link: https://discovery.ucl.ac..

5

AAV9-mediated SH3TC2 gene replacement therapy targeted to S..:

Georgiou, E ; Kagiava, A ; Sargiannidou, I...
https://discovery.ucl.ac.uk/id/eprint/10178813/1/1-s2.0-S1525001623004525-main.pdf. , 2023

Link: https://discovery.ucl.ac..

6

Efficacy of AAV serotypes to target Schwann cells after int..:

Kagiava, A ; Richter, J ; Tryfonos, C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640002/. , 2021

Link: http://www.ncbi.nlm.nih...

7

AAV9-mediated Schwann cell-targeted gene therapy rescues a ..:

Kagiava, A ; Karaiskos, C ; Richter, J...
https://discovery.ucl.ac.uk/id/eprint/10124367/1/s41434-021-00250-0.pdf. , 2021

Link: https://discovery.ucl.ac..

8

Gene replacement therapy after neuropathy onset provides th..:

Kagiava, A ; Richter, J ; Tryfonos, C...
https://zenodo.org/record/3839275. , 2019

Link: https://zenodo.org/recor..

9

Gene replacement therapy in a model of Charcot-Marie-Tooth ..:

Schiza, N ; Georgiou, E ; Kagiava, A...
https://discovery.ucl.ac.uk/id/eprint/10072067/3/Schiza_awz064.pdf. , 2019

Link: https://discovery.ucl.ac..

10

Gene replacement therapy after neuropathy onset provides th..:

Kagiava, A ; Richter, J ; Tryfonos, C...
https://discovery.ucl.ac.uk/id/eprint/10080259/3/Heslegrave%20Late%20Cx32KO%20treatment%2031-3-19.pdf. , 2019

Link: https://discovery.ucl.ac..

11

Golgi-retained Cx32 mutants interfere with gene addition th..:

Kyriakoudi, S ; Sargiannidou, I ; Kagiava, A..
https://discovery.ucl.ac.uk/id/eprint/10044682/1/Kyriakoudi%20HMG%20.pdf. , 2017

Link: https://discovery.ucl.ac..

12

Systemic inflammation disrupts oligodendrocyte gap junction..:

Olympiou, M ; Sargiannidou, I ; Markoullis, K...
https://discovery.ucl.ac.uk/id/eprint/10038803/1/s40478-016-0369-5.pdf. , 2016

Link: https://discovery.ucl.ac..

13

O-4. The effects of CMT1X mutations in myelinating cells:

Sargiannidou, I ; Vavlitou, N ; Hadjisavvas, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859651. , 2009

Link: http://www.ncbi.nlm.nih...

14

Efficacy of AAV serotypes to target Schwann cells after int..:

A. Kagiava ; J. Richter ; C. Tryfonos...
https://doi.org/10.1038/s41598-021-02694-1. , 2021

Link: https://doi.org/10.1038/..

15

Aberrant Mitochondrial Dynamics and Exacerbated Response to..:

Stavropoulos, Filippos ; Sargiannidou, Irene ; Potamiti, Louiza...
International Journal of Molecular Sciences. 22 (2021) 21 - p. 11569 , 2021

Link: https://doi.org/10.3390/..